Skip to content

White House Flags China as Equal R&D Rival to United States

By News Analysis India · · 2 min read

In a comprehensive science‑policy review released Tuesday, the White House Office of Science and Technology Policy warned that China has become a genuine peer competitor to the United States in research and development spending. The report, called “Science: A New Golden Age,” draws on purchasing‑power‑parity (PPP) metrics to show that China’s R&D outlays now match the roughly $200 billion annual federal budget of the United States.

The assessment spans the last twenty years, during which Beijing’s systematic investment has lifted its research capacity to the same magnitude as America’s. A comparative chart featuring the U.S., China, and the 27 EU member states underscores that, for the first time, the United States faces a nation with comparable PPP‑adjusted R&D intensity.

According to the document, China has embedded scientific research at the core of its global competitiveness strategy. Decision‑making authority is centralized, and cross‑sector coordination ensures that resources flow toward both foundational science and high‑priority technologies. This inclusive, society‑wide approach has allowed China to secure funding for basic research, accelerate advances in strategic tech fields, and tighten its innovation cycle.

The report also highlights China’s development of autonomous scientific laboratories—facilities that employ artificial intelligence and robotics to design and conduct experiments with minimal human oversight. While the United States has begun piloting similar autonomous labs in its national research complexes, the analysis notes that Canada, China and other nations are progressing at a faster pace.

The White House blueprint advises concentrating federal dollars on eight priority areas: artificial intelligence, quantum computing, semiconductors, nuclear fission and fusion, advanced communications, robotics, manufacturing, and space systems. Notably, the document makes no reference to India or Indian research institutions, nor does it list India as a prospective partner in any of the outlined technology missions.

A separate memorandum attached to the FY 2028 research agenda grants agencies the flexibility to explore funding projects that involve cost‑sharing with “international partners.” The text, however, stops short of naming any specific nation or research field for such collaborations.

Beyond China, the report cites other countries that have undertaken significant reforms. The United Kingdom is praised for reorganizing its science‑funding architecture and launching a “meta‑science unit” in 2024 to evaluate funding mechanisms and peer‑review credibility. Norway’s portfolio‑based research council is highlighted as a model for allocating funds based on long‑term national research plans.

Historical parallels are drawn to the late‑1980s, when Japanese firms dominated the global memory‑chip market, prompting the creation of a U.S. semiconductor consortium backed by the federal government. The paper warns that many American inventions have been commercialized abroad, pointing out that the sole maker of extreme‑ultraviolet lithography machines is based in Europe, while Asian firms control the lithium‑ion battery supply chain.

Finally, the analysis reflects on post‑World War II reforms to the U.S. research system and cites Vannevar Bush’s 1945 work “Science: The Endless Frontier” as a milestone. It concludes that the appearance of a true R&D peer and the rapid rise of AI make another deep‑seated restructuring of the American research enterprise essential.